Faculty Opinions recommendation of Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.

Rémy Bosselut(National Institutes of Health)
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
June 4, 2018
Cited by 0


Related Papers